BeyondSpring, Inc. - Ordinary Shares (BYSI) earnings
BYSI earnings moved a median of -2.05% by the close. Quarterly and annual BYSI reports and results, each read against the price at its own news timestamp. Back to the BYSI overview →
15 measured BYSI earnings events.
Where these BYSI earnings landedvs 14 measured BYSI earnings reactions
| Middle 50% of BYSI earnings reactions | -4.76% to +3.35% |
|---|---|
| Median reaction (to close) | -2.05% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 BYSI earnings events with a measured close landed between -4.76% and +3.35%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update | Press release | -3.57% | -15.30% | |
| Form 10-Q BeyondSpring Inc. For: Jun 30 | SEC filing · Form 10-Q | -3.57% | -15.30% | |
| BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update | Press release | — | +2.84% | |
| Form 10-Q BeyondSpring Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +3.52% | |
| BeyondSpring Files 2025 Annual Report on Form 10-K | Press release | — | -3.59% | |
| Form 10-K BeyondSpring Inc. For: Dec 31 | SEC filing · Form 10-K | — | -3.59% | |
| BeyondSpring Reports Third-Quarter 2025 Financial Results and Provides Corporate Update | Press release | +0.00% | +10.42% | |
| Form 10-Q BeyondSpring Inc. For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| BeyondSpring Reports Second-Quarter 2025 Financial Results and Provides Corporate Update: Accelerates Momentum with Promising Clinical Advances and Strategic Leadership Appointment | Press release | +0.00% | -0.50% | |
| Form 10-Q BeyondSpring Inc. For: Jun 30 | SEC filing · Form 10-Q | — | +0.50% | |
| BeyondSpring Reports First-Quarter 2025 Financial Results and Provides Corporate Update | Press release | +0.00% | +4.25% | |
| Form 10-Q BeyondSpring Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +4.25% | |
| BeyondSpring Files 2024 Annual Report on Form 10-K | Press release | +0.00% | -4.76% | |
| Form 10-K BeyondSpring Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -4.76% | |
| BeyondSpring Files 2023 Annual Report on Form 20-F | Press release | +0.00% | -8.64% |
Keep exploring
More BYSI: analyst actions → · SEC filings → · BYSI overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| INMED PHARMACEUTICALS (IMLFF) | 148 | 0.00% | 48% |
| Akari Therapeutics Plc - American Depositary Shares (AKTX) | 146 | 0.00% | 45% |
| Clearside Biomedical, Inc. (CLSD) | 145 | 0.00% | 46% |
| Oramed Pharmaceuticals Inc. (ORMP) | 145 | +0.69% | 69% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.